Matrix Metalloproteinases Are Involved in the Development of Neurological Complications in Patients With Coronavirus Disease 2019 Publisher Pubmed



Mohammadhosayni M^{1, 2} ; Sadat Mohammadi F³ ; Ezzatifar F^{4, 5} ; Mahdavi Gorabi A⁶ ; Khosrojerdi A⁷ ; Aslani S⁸ ; Hemmatzadeh M⁹ ; Yazdani S¹⁰ ; Arabi M¹¹ ; Marofi F¹² ; Jadidiniaragh F^{13, 14} ; Shomali N⁹ ; Mohammadi H^{15, 16} Show Affiliations
Source: International Immunopharmacology Published:2021

Abstract

Background: Evidence show that Matrix metalloproteinases (MMPs) have been associated with neurological complications in the viral infections. Here in the current investigation, we intended to reveal if MMPs are potentially involved in the development of neurological symptoms in the patients with Coronavirus disease 2019 (COVID-19). Methods: The levels of MMPs, inflammatory cytokines, chemokines, and adhesion molecules were evaluated in the serum and cerebrospinal fluid (CSF) samples from 10 COVID-19 patients with neurological syndrome (NS) and 10 COVID-19 patients lacking NS. Monocytes from the CSF samples were treated with TNF-α and the secreted levels of MMPs were determined. Results: The frequency of monocytes were increased in the CSF samples of COVID-19 patients with NS compared to patients without NS. Levels of inflammatory cytokines IL-1β, IL-6, and TNF-α, chemokines CCL2, CCL3, CCL4, CCL7, CCL12, CXCL8, and CX3CL1, MMPs MMP-2, MMP-3, MMP-9, and MMP-12, and adhesion molecules ICAM-1, VCAM-1, and E-selectin were significantly increased in the CSF samples of COVID-19 patients with NS compared with patients without NS. Treatment of CSF-derived monocytes obtained from COVID-19 patients with NS caused increased production of MMP-2, MMP-3, MMP-9, and MMP-12. Conclusions: Higher levels of inflammatory cytokines might promote the expression of adhesion molecules on blood-CSF barrier (BCSFB), resulting in facilitation of monocyte recruitment. Increased levels of CSF chemokines might also help to the trafficking of monocytes to CSF. Inflammatory cytokines might enhance production of MMPs from monocytes, leading to disruption of BCSFB (and therefore further infiltration of inflammatory cells to CSF) in COVID-19 patients with NS. © 2021 Elsevier B.V.